Ipamorelin 5 mg/Tesamorelin 5 mg Ipamorelin 5 mg/Tesamorelin 5 mg
Dragon Pharma

Ipamorelin 5 mg/Tesamorelin 5 mg

Growth Hormone Secretagogue (Peptide Research Blend)

  • Product: Ipamorelin 5 mg/Tesamorelin 5 mg
  • Peptide Blend:
    • Ipamorelin 5 mg
    • Tesamorelin 5 mg
  • Total Strength: 10 mg/vial
  • Container: 2 mL vial
  • Manufacturer: Dragon Pharma
$42.00 $70.00
Warehouse :
International
U.S. Domestic
You will save $28.00

Dragon Pharma Peptide Product

Dragon Pharma Ipamorelin/Tesamorelin Overview

Dragon Pharma Ipamorelin/Tesamorelin is supplied as a lyophilized powder in a 2 mL vial and contains a combination of two growth hormone-releasing peptides: ipamorelin and tesamorelin, each at a labeled strength of 5 mg. Product specifications, a batch-specific lab report, storage information, and available payment options are provided below.

5 mg / 5 mg Peptide Blend

Contains equal amounts (5 mg each) of ipamorelin and tesamorelin per vial.

Lyophilized Powder Form

Supplied as a freeze-dried powder requiring reconstitution with bacteriostatic water before use.

2 mL Vial

Packaged in a standard 2 mL peptide vial with a rubber stopper and aluminum seal.

Published Lab Report

A published lab report from November 2025 provides measured results for the identified batch.

Product Specifications

Product name Ipamorelin 5 mg/Tesamorelin 5 mg
Active substances Ipamorelin (5 mg), Tesamorelin (5 mg)
Total labeled strength 10 mg/vial
Container 2 mL vial
Total labeled content 10 mg per vial
Product form Lyophilized powder
Manufacturer Dragon Pharma

Latest Lab Result

The latest published report for batch #HDIT10, dated November 10, 2025, measured 5.47 mg of ipamorelin and 5.33 mg of tesamorelin against the stated 5 mg labeled strength for each peptide.

Open the Lab Reports tab to view the full report and check the batch number associated with the test.

Related Peptide Options

Other peptide options from the same product line include Ipamorelin 5 mg as a single-peptide product, Tesamorelin 5 mg individually, and CJC-1295 No DAC/Ipamorelin, which combines ipamorelin with CJC-1295 No DAC. These products differ in their peptide composition and research applications.

Published Test Result

Dragon Pharma Ipamorelin/Tesamorelin Lab Report

A published lab report for Dragon Pharma Ipamorelin/Tesamorelin is provided below with the test date, measured results and reported batch number. Each result can be compared directly with the product's labeled strength of 5 mg per peptide.

Science & Research

Understanding Ipamorelin and Tesamorelin

Ipamorelin and tesamorelin are synthetic peptides that act on the growth hormone axis through different mechanisms. This section provides a brief overview of what is known about these peptides from research literature.

1

Ipamorelin

Ipamorelin is a growth hormone-releasing peptide (GHRP) that acts on the ghrelin receptor to stimulate growth hormone release. It has a relatively low effect on appetite and cortisol levels in research settings compared with some other GHRPs.

2

Tesamorelin

Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to release growth hormone through the GHRH receptor pathway.

3

Combined Mechanism

Combining a GHRP (ipamorelin) with a GHRH analogue (tesamorelin) uses two distinct pathways to promote growth hormone secretion, which may produce a different effect compared with either peptide used alone.

Peptide Reconstitution and Use

This product is supplied as a lyophilized powder and must be reconstituted with bacteriostatic water or sterile water for injection before use. The addition of water converts the freeze-dried powder into a solution suitable for research applications.

The reconstituted peptide solution should be stored as recommended on the product label. Peptide solutions are typically refrigerated and used within a specified timeframe after reconstitution to maintain integrity.

Research References

Peer-reviewed research on ipamorelin and tesamorelin is available through the National Institutes of Health and other scientific databases. The following links provide general information on these peptides and their mechanisms of action.

Important Health Information

Ipamorelin/Tesamorelin Safety Information

Peptide research compounds such as those in this blend have limited clinical safety data. The information below is derived from published preclinical research and general knowledge of the growth hormone axis and does not constitute medical advice.

Limited Clinical Data

Ipamorelin and tesamorelin have not been extensively studied in humans in combination. The available safety information comes primarily from preclinical research.

Growth Hormone Effects

Peptides that stimulate growth hormone release have the potential to affect glucose metabolism, insulin sensitivity and fluid balance. These effects are not well characterized for this combination.

Injection-Related Risks

Subcutaneous injection carries risks including injection-site reactions, infection and improper technique. Sterile handling and correct reconstitution procedures are essential.

Hormonal Interactions

Compounds that affect the growth hormone axis may interact with other hormonal systems, including thyroid and adrenal function. The potential significance of these interactions is not fully understood.

Central Nervous System Effects

Growth hormone-releasing peptides may have central nervous system effects in preclinical research, including effects on sleep and appetite. The clinical significance of these findings is unknown.

Contraindications

This peptide research compound should not be used by individuals with known allergies or sensitivities to peptide compounds, or by those who are pregnant, nursing or have active malignancies.

Conditions That Require Medical Review

Medical advice is particularly important for individuals with diabetes or glucose metabolism disorders, cardiovascular disease, cancer or a history of cancer, pituitary disorders, or those taking medications that affect hormone levels. This peptide blend should not be used during pregnancy or breastfeeding.

The product should also be stored securely to prevent accidental access or use by children or other household members, particularly after reconstitution when it contains a liquid solution.

Tested Sport

Growth hormone-releasing peptides, including ipamorelin and tesamorelin, are prohibited under anti-doping rules in tested sport at all times unless an applicable therapeutic-use exemption has been granted.

The current status and applicable rules can be checked through the World Anti-Doping Agency Prohibited List.

Common Product Questions

Dragon Pharma Ipamorelin/Tesamorelin FAQ

Quick answers about Ipamorelin/Tesamorelin specifications, the published lab report, storage, shipping, Bitcoin payment and general product information.

What is Dragon Pharma Ipamorelin/Tesamorelin?

Dragon Pharma Ipamorelin/Tesamorelin is a lyophilized peptide product containing 5 mg of ipamorelin and 5 mg of tesamorelin per vial. It is supplied in a 2 mL vial for research purposes.

What is the difference between ipamorelin and tesamorelin?

Ipamorelin is a growth hormone-releasing peptide (GHRP) that acts on the ghrelin receptor, while tesamorelin is a GHRH analogue that acts on the GHRH receptor. They stimulate growth hormone release through different pathways.

How much of each peptide is in the vial?

Each vial contains a labeled strength of 5 mg of ipamorelin and 5 mg of tesamorelin, for a total of 10 mg of peptide content per vial.

How is the product supplied?

The product is supplied as a lyophilized powder in a 2 mL vial. It requires reconstitution with bacteriostatic water or sterile water for injection before use.

What did the lab report show for this product?

The published lab report dated November 10, 2025 for batch #HDIT10 measured 5.47 mg of ipamorelin and 5.33 mg of tesamorelin against the stated 5 mg labeled strength for each peptide.

Does the lab report verify every vial?

No. Each report applies to the sample submitted for that specific test and the batch identified in the report. It does not independently verify the content or condition of every individual vial.

How should this peptide blend be stored?

Store the lyophilized powder in its original packaging at room temperature or refrigerated, protected from excessive heat, moisture and direct light. Once reconstituted, peptide solutions typically require refrigeration and should be used within a limited timeframe. Always follow the specific storage directions printed on the product label.

Does Ipamorelin/Tesamorelin require refrigeration?

Lyophilized peptide powders are generally stable at room temperature but should be protected from heat. After reconstitution, peptide solutions typically require refrigeration. Check the product label for specific storage instructions.

How long does Ipamorelin/Tesamorelin delivery take?

Delivery depends on the warehouse selected for the order. Shipments from the USA Warehouse typically take 4–5 business days after dispatch, while shipments from the International Warehouse typically take 15–20 business days after dispatch. Full delivery and reship information is available on the Shipping Information page.

Can I buy Ipamorelin/Tesamorelin with Bitcoin?

Yes. Bitcoin and other supported cryptocurrencies are available at checkout for all orders. To buy Ipamorelin/Tesamorelin with Bitcoin, select Bitcoin as the payment method during checkout and follow the payment instructions provided with the order.

Is Bitcoin payment anonymous?

Bitcoin transactions are recorded on a public blockchain and should not be considered automatically anonymous. Accurate order and delivery information is still required for order processing and shipping.

Is Ipamorelin/Tesamorelin permitted in tested sport?

Growth hormone-releasing peptides, including ipamorelin and tesamorelin, are prohibited under anti-doping rules in tested sport unless an applicable therapeutic-use exemption has been granted. Current requirements should be checked against the relevant anti-doping rules before competition.

Where can I find more information on these peptides?

Additional research on ipamorelin and tesamorelin is available through the National Institutes of Health and other scientific databases. Direct links to PubMed references are provided in the Science & Research section above.

No reviews found

Please log in to write Ipamorelin 5 mg/Tesamorelin 5 mg review.

Related Offers
Lab Tested
Domestic & International
-40% OFF
BPC 157 5 mg
Dragon Pharma, Europe

Peptide Research Compound

  • Product: BPC 157 5 mg
  • Active Substance: Pentadecapeptide
  • Strength: 5 mg/vial
  • Container: 2 mL vial
  • Manufacturer: Dragon Pharma
$24.00 $40.00
You will save $16.00
Lab Tested
Domestic & International
-40% OFF
TB 500 5 mg/BPC 157 5 mg
Dragon Pharma, Europe

Tissue Repair Peptide Blend

  • Product: TB 500 5 mg/BPC 157 5 mg
  • Peptide Blend:
    • TB 500 5 mg
    • BPC 157 5 mg
  • Total Strength: 10 mg/vial
  • Container: 2 mL vial
  • Manufacturer: Dragon Pharma
$48.00 $80.00
You will save $32.00
Lab Tested
Domestic & International
NEW
-40% OFF
GHK-Cu 50 mg
Dragon Pharma, Europe

Copper Peptide / Tissue Research

  • Product: GHK-CU 50 mg
  • Active Substance: GHK-CU
  • Strength: 50 mg/vial
  • Container: 2 mL vial
  • Manufacturer: Dragon Pharma
$27.00 $45.00
You will save $18.00

Add to Cart - Product(s)

Close Button
Empty

Total Cost: